Lipid dysregulation of immune mediated intestinal epithelial healing

免疫介导的肠上皮愈合的脂质失调

基本信息

  • 批准号:
    10359804
  • 负责人:
  • 金额:
    $ 15.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-07 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

Lipid dysregulation of immune mediated intestinal epithelial healing A single layer of epithelial cells protects us from harmful interactions with the intestinal microbiota and harmful agents we inhale and ingest daily. Unresolved damage to this epithelial layer can lead to the development of chronic inflammatory diseases, including inflammatory bowel disease (IBD). High fat diets (HFD) correspond to increased incidence and severity of many chronic inflammatory diseases. Diets high in fat have been demonstrated to directly induce pro-inflammatory functions in macrophages, promoting chronic inflammation. In the intestine, HFD has been shown to decrease barrier function and promote chronic inflammation. However, it’s impact on intestinal immune function and tissue repair processes is less understood. Our immune system supports the proper functioning of tissue barriers. In response to tissue damage, tissue macrophages induce pro-inflammatory immune functions aiding in protection from pathogens. In the resolution phase of this response, these cells produce anti-inflammatory cytokines to dampen inflammation and promote tissue repair. Perturbations to any aspect of this response can lead to ineffective repair of tissue injury and development of inflammation. A key signal involved in this molecular switch of macrophages from pro- to anti-inflammatory responses is clearance of apoptotic cells, specifically apoptotic neutrophils. Defects in this response have been linked to many auto-immune and chronic inflammatory diseases including lupus, type 1 diabetes, atherosclerosis, COPD and cardiovascular disease. Tissue macrophages are important in intestinal homeostasis and their dysfunction is thought to drive disease pathogenesis in IBD. Further, defective barrier repair is seen in intestinal disease, but it is unclear whether defective apoptotic cell clearance by intestinal macrophages is involved and what mechanisms could modulate this process. To determine the impact of HFD on intestinal tissue repair responses, we utilized short-term HFD feeding in the context of mouse models of intestinal injury. Our data demonstrates that HFD increases susceptibility to colitis with increased weightloss, aberrant epithelial cell proliferation, loss of goblet cells and tight junction proteins necessary to prevent microbial penetration into the body. Further, we identified dysregulated immune responses resulting in an inability of intestinal immune cells to properly support barrier function and repair. We also find that HFD alters macrophage responses to and clearance of apoptotic neutrophils. Together, we find that HFD feeding directly promotes altered functions of intestinal immune cells leading to barrier repair defects. These findings led us to hypothesize that dietary lipids directly interfere with apoptotic cell recognition and uptake receptors and activation of downstream pro-repair signaling pathways resulting in dysregulated intestinal barrier repair. This is the basis of my K01 application.
免疫介导的肠上皮愈合过程中的脂质失调 单层上皮细胞保护我们免受与肠道微生物区系的有害相互作用 我们每天吸入和摄入的毒剂。对这一上皮层的未解决的损害可能导致 慢性炎症性疾病,包括炎症性肠病。高脂饮食(HFD)对应于 许多慢性炎症性疾病的发病率和严重性增加。高脂肪饮食一直是 证明能直接诱导巨噬细胞的促炎功能,促进慢性炎症。在……里面 在肠道,HFD已被证明降低屏障功能,促进慢性炎症。然而, 它对肠道免疫功能和组织修复过程的影响尚不清楚。 我们的免疫系统支持组织屏障的正常运作。作为对组织损伤的反应, 组织巨噬细胞诱导促炎免疫功能,有助于保护机体免受病原体侵袭。在 在这一反应的解决阶段,这些细胞产生抗炎细胞因子来抑制炎症和 促进组织修复。对这种反应的任何方面的干扰都可能导致组织损伤的无效修复 以及炎症的发展。巨噬细胞从亲本到亲本的分子转换过程中的一个关键信号 抗炎反应是清除凋亡细胞,特别是凋亡的中性粒细胞。这里面的瑕疵 反应与许多自身免疫和慢性炎症性疾病有关,包括1型狼疮 糖尿病、动脉粥样硬化、慢性阻塞性肺病和心血管疾病。组织巨噬细胞在肠道中很重要 动态平衡及其功能障碍被认为是IBD疾病发病机制的驱动因素。此外,有缺陷的障碍 肠道疾病中可以看到修复,但尚不清楚肠道中是否存在缺陷的凋亡细胞清除 巨噬细胞参与其中,以及什么机制可以调节这一过程。 为了确定HFD对肠道组织修复反应的影响,我们采用了短期HFD喂养 在小鼠肠道损伤模型的背景下。我们的数据表明,HFD增加了对 结肠炎,体重增加,上皮细胞异常增殖,杯状细胞丢失,紧密连接 防止微生物渗入体内所需的蛋白质。此外,我们还发现免疫功能失调 导致肠道免疫细胞无法正确支持屏障功能和修复的反应。我们 还发现HFD改变了巨噬细胞对凋亡中性粒细胞的反应和清除。共同努力,我们发现 HFD喂养直接促进肠道免疫细胞功能改变,导致屏障修复缺陷。 这些发现使我们假设饮食中的脂类直接影响细胞对凋亡的识别和摄取。 受体和下游促修复信号通路的激活导致肠屏障功能失调 修理。这是我K01申请的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrea Alyssa McAlester其他文献

Andrea Alyssa McAlester的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrea Alyssa McAlester', 18)}}的其他基金

Lipid dysregulation of immune mediated intestinal epithelial healing
免疫介导的肠上皮愈合的脂质失调
  • 批准号:
    9976797
  • 财政年份:
    2020
  • 资助金额:
    $ 15.29万
  • 项目类别:
Lipid dysregulation of immune mediated intestinal epithelial healing
免疫介导的肠上皮愈合的脂质失调
  • 批准号:
    10579908
  • 财政年份:
    2020
  • 资助金额:
    $ 15.29万
  • 项目类别:
Lipid dysregulation of immune mediated intestinal epithelial healing
免疫介导的肠上皮愈合的脂质失调
  • 批准号:
    10833378
  • 财政年份:
    2020
  • 资助金额:
    $ 15.29万
  • 项目类别:
The role of NF-kB in ATM Survival
NF-kB 在 ATM 生存中的作用
  • 批准号:
    8596977
  • 财政年份:
    2013
  • 资助金额:
    $ 15.29万
  • 项目类别:
The role of NF-kB in ATM Survival
NF-kB 在 ATM 生存中的作用
  • 批准号:
    8737019
  • 财政年份:
    2013
  • 资助金额:
    $ 15.29万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 15.29万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 15.29万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 15.29万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 15.29万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 15.29万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 15.29万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 15.29万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 15.29万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 15.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了